Comparison of Cr-EDTA and Tc-DTPA for Glomerular Filtration Rate Measurement
Overview
Authors
Affiliations
Purpose: The production of Cr-labelled ethylenediaminetetraacetic acid (Cr-EDTA), a validated and widely used radio-isotopic tracer for glomerular filtration rate (GFR) measurement in Europe, was recently halted by the manufacturer. Technetium-99m-diethylenetriaminepentaacetic acid (Tc-DTPA) clearance has so far mostly been restricted to assessment of separate renal function by scintigraphy, but scarcely used and validated for GFR measurement. We compared the performances of Cr-EDTA and Tc-DTPA for GFR and extracellular fluid measurement.
Methods: In a multi-centre prospective study, Cr-EDTA and Tc-DTPA were simultaneously injected into 88 patients, and their urinary and plasma clearances, as well as their volumes of distribution, were measured during seven 30-min periods after a 90-min equilibrium time.
Results: Mean age was 52.2 ± 14.5 years, 59% were men. Urinary clearances of Cr-EDTA and Tc-DTPA were 64.1 ± 27.6 and 66.1 ± 28.0 mL/min, respectively, with a mean bias of 2.00 ± 2.25 mL/min, an accuracy within 10% of 95% [95% CI 91-99], and a coefficient of determination (R) of 0.994. Plasma clearances of Cr-EDTA and Tc-DTPA were 66.1 ± 25.8 and 68.1 ± 26.6 mL/min, respectively, with a mean bias of 1.96 ± 3.32 mL/min, an accuracy within 10% of 91% [95% CI 85-97] and a R of 0.985. Distribution volumes were 17.3 ± 4.6 L for Cr-EDTA and 16.6 ± 4.6 L for Tc-DTPA (R 0.930).
Conclusion: The accuracy and precision of Tc-DTPA clearance, compared to Cr-EDTA clearance, was excellent for both urinary and plasma clearance methods, despite an approximate 2 mL/min overestimation, showing that the tracer is a reliable alternative to Cr-EDTA for GFR measurement.
Motiejunaite J, Flamant M, Arnoult F, Lahens A, Tabibzadeh N, Boutten A Hypertens Res. 2024; 47(9):2511-2520.
PMID: 38969804 DOI: 10.1038/s41440-024-01778-5.
Mortensen L, Jespersen B, Helligsoe A, Tougaard B, Cibulskyte-Ninkovic D, Egfjord M Clin J Am Soc Nephrol. 2024; 19(6):755-766.
PMID: 38416033 PMC: 11168825. DOI: 10.2215/CJN.0000000000000439.
Zingano C, Escott G, Rocha B, Porgere I, Moro C, Delanaye P Clin Kidney J. 2023; 16(2):322-330.
PMID: 38021375 PMC: 10665997. DOI: 10.1093/ckj/sfac238.
Lambert M, Alonso M, Munzer C, Zimoch M, Malard L, Gambart M Cancer Chemother Pharmacol. 2023; 93(4):393-395.
PMID: 37789166 DOI: 10.1007/s00280-023-04597-6.
Balouzet C, Michon-Colin A, Dupont L, Vidal-Petiot E, Prot-Bertoye C, Baron S J Nephrol. 2023; 36(9):2457-2465.
PMID: 37093492 DOI: 10.1007/s40620-023-01612-0.